Many hospitals, and medical and dental clinics and offices, routinely monitor their procedural-sedation practicesd tracking adverse events, outcomes, and efficacy in order to optimize the sedation delivery and practice. Currently, there exist substantial differences between settings in the content, collection, definition, and interpretation of such sedation outcomes, with resulting widespread reporting variation. With the objective of reducing such disparities, the International Committee for the Advancement of Procedural Sedation has herein developed a multidisciplinary, consensusbased, standardized tool intended to be applicable for all types of sedation providers in all locations worldwide. This tool is amenable for inclusion in either a paper or an electronic medical record. An additional, parallel research tool is presented to promote consistency and standardized data collection for procedural-sedation investigations.
modalities, and the collection and review of quality-assurance data have advanced the safety profile for sedation practice and minimized the occurrence of serious adverse outcomes. 4e6 Given their rarity, death and permanent neurological disability cannot be easily tracked as primary outcomes for sedation-quality-improvement processes. It is instead necessary to target and monitor the more frequent events and interventions that may signify the approach of such risks, such as apnea or the necessity for breathing rescue with positive pressure ventilation. Although widely referred to as 'adverse events' and sometimes considered 'near misses' or 'close calls', these occurrences, in fact, rarely pose any serious danger of death or neurological injury when identified promptly and managed with appropriate intervention.
1e3, 7 The frequency and severity of these events and interventions are commonly used as surrogate markers to estimate risk and the overall safety (presumed or actual) of a given sedation system.
The reporting of such sedation-related outcomesdwhether for quality improvement or for researchdhas always been subject to substantial variability, and there exist diverse assertions as to what specific events constitute reasonable surrogate markers for risk. A major limitation of commonly used time and severity thresholds is that they are inconsistently reported between, and within, settings. For example, is hypoxia defined by an oxygen saturation of <93%, 8 <92%, 9 <90%, 10 or <85%? 11 Qualifiers of duration are challenging for clinicians to accurately determine in clinical settings, even with electronic record keeping (e.g. did the oxygen-desaturation duration exceed 30 s?). This dissimilar taxonomy of adverse events and outcomes thwarts the reliable comparison of research or quality-assurance data between settings, hinders systematic reviews, and impairs our ability to develop benchmarks that would permit the identification of areas of strength and weakness globally, and between and within specific sedation systems. 12, 13 To resolve these challenges, the International Committee for the Advancement of Procedural Sedation (ICAPS, www. ProceduralSedation.org) has herein developed a multidisciplinary, consensus-based, standardized quality-improvement tool intended to be applicable for all types of sedation providers in all locations worldwide. This tool is suitable for inclusion in either a paper or an electronic medical record. It is founded upon the premise that adverse events are best defined by their associated interventions and patient-centred outcomes.
An additional, parallel research tool is presented to promote consistency and standardized data collection for procedural-sedation investigations.
Methods

Committee
The mission of ICAPS is to provide an independent, international, multidisciplinary forum to facilitate open dialogue and consensus generation between experts in the area of sedation, and to promote optimal, evidence-based, safe and effective practices for worldwide procedural sedation and analgesia in patients of all ages. It was founded in 2014 by its co-chairs (S.M.G. and K.P.M.), who invited members based on their established expertise as sedation researchers and leaders, their geographic and practice diversity, and their support for its mission. ICAPS includes members from nine countries on five continents, with representation from anesthesia, critical care, dentistry, emergency medicine, gastroenterology, hospital medicine, and pediatrics (Appendix).
Approach and definitions
In developing this tool, we adhered to the principles and methodology advocated by the Institute of Medicine in their document 'Clinical Practice Guidelines We Can Trust'. 14 We reviewed and debated the merits and broad applicability of existing definitions for sedation adverse events and outcomes reported in prospective research, used by existing sedation research consortia, and advocated by two prior advisories on the topic: the Quebec Guidelines 12 and the World Society of Intravenous Anaesthesia (World SIVA). 15 We defined procedural sedation as 'the use of anxiolytic, sedative, hypnotic, analgesic, and/or dissociative medication(s) to attenuate anxiety, pain, and/or motion. These agents are administered in order to facilitate amnesia or decreased awareness and/or patient comfort and safety during a diagnostic or therapeutic procedure'. 1, 2, 12 We defined a sedation-related adverse event as 'unexpected and undesirable response(s) to medication(s) and medical intervention used to facilitate procedural sedation and analgesia that threaten or cause patient injury or discomfort'. 15 This sedation-specific definition was crafted based on adverse-event wording from the Institute of Medicine, 16 World Health Organization, 17 European Medicines Agency, 18, 19 and the US Food and Drug Administration. 20 
Consensus-generation process
The primary modality for ICAPS consensus generation was a series of internet-based questionnaires constructed and implemented using the principles of the anonymized nominal group technique and the Delphi method. After a general survey of committee members regarding optimal reporting format and content, a committee task force drafted, and then circulated, a preliminary tool structure and definitions. We then initiated a sequential consensusgeneration process using an iterative series of internet surveys. After each round, the responses from all members were displayed to all in an anonymous fashion. The committee members could then revise their earlier responses based upon ongoing feedback, with two co-chairs serving as moderators to guide the direction of consensus discussion. We believe that the process was thus fair and transparent, and it demonstrated a measurable and acceptable degree of final consensus.
After two cycles of formal Delphi review, we generated a provisional tool and definitions. We then submitted this provisional tool for external review by outside professional societies and other organizations with special interest in procedural sedation (http://ProceduralSedation.org/liaisons). The tool was also presented and discussed at the US Food and Drug Administration's Sedation Consortium on Endpoints and Procedures for Treatment, Education, and Research meeting in November 2016, and feedback obtained from this 46-member multidisciplinary panel.
The tool was revised based on this additional feedback, and then underwent a third round of Delphi review. After additional minor edits, the consensus was strong for the final version. The committee members were asked to respond to the following question using a 5-point Likert scale: Does this updated draft represent the best possible tool (as can reasonably be achieved) to standardize continuous qualityimprovement monitoring for all types of sedation providers in all locations? We achieved a strong consensus as per our a priori threshold of 90% 'agree' or 'strongly agree', as follows: strongly disagree (0), disagree (0), no strong opinion (1), agree (6) , and strongly agree (13) .
Results
The committee addressed and resolved five fundamental issues relating to focus, utility, and format of the documentation tool.
Clinical vs research application
The prior World SIVA guidelines 15 were focused upon offering an open-access tool using a standardized terminology to identify and grade the risk of sedation-related adverse events and outcomes, whilst the Quebec Guidelines 12 and researchconsortia reporting structures were focused upon the standardization of research reporting. The ICAPS committee recognized that a single tool could not optimally serve both purposes, and so endorsed the creation of two parallel reporting instruments: the first for clinical quality improvement, and the second to promote consistency in research design.
Logical-tool organization
We wished to make the reporting process intuitive and simple, with the clinical version suitable for medical-record incorporation in either a paper or an electronic format. Recognizing that parsimony was critical to its clinical acceptance, we intentionally did not make the Tracking and Reporting Outcomes of Procedural Sedation (TROOPS) comprehensive. We chose to organize the tool based on organ systems, to better simulate how practitioners logically organize clinical information.
Tool application
TROOPS is intended as a succinct checklist designed to identify sedation encounters with interventions or outcomes significant enough to warrant formal quality-improvement review. It would not replace other separately recorded elements of routine sedation documentation (e.g. pre-sedation evaluation, intra-sedation monitoring, and recovery monitoring). Once flagged for scrutiny by TROOPS, individuals or committees responsible for local quality oversight would then perform a detailed review of the full medical record.
Patient-centred outcomes
The Quebec Guidelines 12 and World SIVA 15 adverse-event outcome tool were mainly focused on using standardized definitions to identify sedation-related adverse events. Our committee also recognized the importance of monitoring patient-centred outcomes, including adequate patient comfort, avoidance of unpleasant recall, facilitation of successful procedure completion, and, ultimately, patient satisfaction. 21 
Standardized nomenclature
A sedation reporting taxonomydparticularly if used for researchdshould ideally be compatible with standardized international medical terminology. 22 Accordingly, we worked closely with the Medical Dictionary for Regulatory Activities (www.MedDRA.org) to ensure effective matching with their coding structure.
Events and thresholds vs interventions
Historically, most sedation-quality assurance and research reporting tools have been predicated on definitions derived from 'events and thresholds'. Examples reported in the literature include apnea for >30 s, oxygen desaturation <90% persisting for 30, end-tidal CO 2 change of >10 mm Hg, and systolic blood pressure <90 mm Hg or below the 5th percentile for age in children.
The primary disadvantage of defining events by the 'threshold and duration' approach is that clinicians rarely agree on optimal thresholdsdhence, the unacceptable diversity of definitions currently in use. Additionally, sedation providers are unlikely to accurately measure the duration of any specific event, given the greater priority of actual patient care and monitoring. Finally, numeric thresholds and durations of events often do not correlate with clinical importance (e.g. a transient, isolated decrease in oxygen saturation to 89%, which spontaneously resolves), and are challenged by patients with atypical baseline values (e.g. oxygen saturation in patients with congenital cardiac conditions, and blood pressure in patients with baseline hypertension).
To counter these limitations, the 2009 Quebec Guidelines for paediatric sedation research 12 advocated the novel alternative approach of defining adverse events based primarily upon interventions performed on their behalf. For example, they defined oxygen desaturation not using any specific numerical threshold, but rather as 'oxygen desaturation and one or more interventions [are] performed with the intention of improving the oxygen saturation'.
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A strength of the Quebec approach is that the act of performing an intervention is typically objective and unambiguous, and thus more likely to be reported in a standardized, reproducible fashion. Just as importantly, intervention-based definitions will better predict clinical importance, as any event would almost certainly be trivial if no intervention was performed in response to its occurrence.
The principal limitation of using interventions to define sedation adverse events and outcomes and to characterize the severity of these events is the natural variation in clinical practice. Individual clinician thresholds for interventions may also change over time; however the goal of TROOPS is to identify and report unexpected adverse events, which if allowed to progress without intervention would result in patient harm. Interventions in response to expected events (e.g., transient clinically unimportant hypotension with propofol) would not be reportable using TROOPS.
To further emphasize this point, not all interventions used to define adverse events are of equal clinical importance. Hypoxia leading to tracheal intubation, as compared with hypoxia that results from a slow decline in oxygen saturation from 100% to 95% for which the sedation provider elected to add supplemental oxygen by nasal cannula as a non-urgent precaution, would both be coded as 'oxygen desaturation'ddespite the very different severity of the event and The 2012 World SIVA tool 15 incorporated an amalgamated taxonomy largely based on interventions, but alsodas a failsafedincluded event threshold and duration-based descriptors of the most serious adverse events and outcomes. After extensive consultation, discussion, and weighing of the issues, the ICAPS committee concluded that the inclusion of arbitrary, controversial, and irreconcilable time and threshold parameters would limit the consistency, clinical utility, and widespread acceptance of our documentation tool. The committee adopted the Quebec Guidelines 12 paradigm of restricting the tool to interventions and outcomes that are objective, unambiguous, and consistent with our stated goals.
Planned versus unplanned
Our ICAPS Committee deliberations uncovered an important and relevant element of sedation practice variation. The committee members who were not anaesthetists, consistently believed that the administration of small boluses of vasoconstrictors and the use of positive pressure mask ventilation represented unplanned rescue interventions, contending that their sedation practice was targeted to avoid these interventions. Our anaesthetists, on the other hand, regarded these two interventions as common and unremarkable, as presumably their anaesthesia expertise rendered them comfortable targeting deeper sedation endpoints. Given our goal of gearing TROOPS towards the needs of all sedation providers, we qualified that all reportable interventions in our tool be "unplanned". For most sedation providers these two specific interventions would always be unplanned, while many anaesthetists would be essentially pre-planning their regular application based upon their deep sedation practice style. TROOPS records only unplanned interventions.
Discussion
Tool organization
Our process created two separate parallel tools: one for routine quality-improvement monitoring, and a second for procedural-sedation research. 
Quality-improvement tool
In Fig. 1 
Research tool
In Fig. 2 , we present the TROOPS comprehensive research tool, which includes additional minor and intermediate interventions that we believe are optimal for general research reporting. It can readily be customized for specific research objectives and is available for download or for open-access registration and personal or group data collection at www. TROOPS-sedation.com.
Related issues
We provide explanations for certain committee decisions. First, we did not provide a mechanism to specifically document multiple occurrences of the same intervention or outcome, considering that, should such recurrences become clinically important, they then would lead to other tool interventions/outcomes; e.g. recurrent positive pressure ventilation would lead to tracheal intubation or administration of reversal drug(s). In the unlikely event that recurrent events might be clinically important without triggering other interventions/outcomes, clinicians could readily provide such documentation in the 'other' free text reporting field.
Second, airway repositioning was not included in the clinical tool, because the committee felt that this was a common and minor aspect of standard procedural-sedation care, and would therefore not be sufficiently serious in and of itself to require specific reporting. Should such airway positioning become sufficiently problematic, it would lead to other interventions/outcomes in the tool.
Third, certain serious interventions (e.g. defibrillation and pharmacological anti-dysrhythmic therapy) are omitted because they are either previously unreported in the literature or exceptionally rare complications of procedural sedation. Their presence would thus add unnecessary complexity to the tool, and in the unlikely event of their occurrence, the clinician or researcher could readily provide documentation using the 'other' free text reporting field.
Fourth, atropine administration for bradycardia was omitted because of redundancy; as in the setting of procedural sedation, its expected precipitant would be hypoxia, which would have already prompted other TROOPS rescue interventions. Alternatively, bradycardia could result from the specific administration of dexmedetomidine, which, if considered clinically important, would be treated with infusion discontinuation rather than administration of an anticholinergic. 24 In the unlikely event of an anticholinergic being administered in the absence of other interventions, clinicians can readily record this in the 'other' free text reporting field. Fifth, anaphylaxis was reserved for the research tool (Fig. 2) , as the quality-improvement tool already captures serious interventions associated with anaphylaxis, such as positive pressure ventilation, tracheal intubation, vasoactive drug administration, or bolus IV fluids. The American Academy of Allergy, Asthma and Immunology distinguishes anaphylaxis from an allergic reaction by noting that it involves more than one system of the body, 25 and thus making anaphylaxis compatible with minor and serious findings and interventions.
Implications
We present a sedation-outcome monitoring tool that we believe is suitable for all sedation providers in all venues and for patients of all ages. The widespread adoption of the TROOPS quality-improvement tool would create a common language to standardize and simplify procedural-sedationoutcome monitoring. It would allow practice patterns to be more reliably contrasted between institutions, regions, and individuals. For research, the widespread adoption of TROOPS would permit something thus far unattainabledthe aggregation of multiple studies using identical definitions for the studied outcomes as part of systematic reviews and meta-analyses.
With the objective of reducing current reporting disparities, the ICAPS presents the first multidisciplinary, consensusbased, standardized quality-improvement tool, www. TROOPS-sedation.com, intended to be applicable for all types of sedation providers in all locations worldwide. An additional, parallel research tool is presented to promote consistency and standardized data collection for procedural-sedation investigations.
